Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).
Alembic Pharms. Ltd. v. Daiichi Sankyo Co., Ltd., 16-3956 (N.D. Ill.) Apr. 1, 2016 Hon. John Z. Lee Benicar® (olmesartan medoxomil tablets) 6,878,703
Merck Sharp & Dohme Corp. v. Roxane Labs., Inc., 16-0285 (S.D. Ohio) Apr. 1, 2016 Hon. James L. Graham Noxafil® (posaconazole oral suspension)
5,661,151
6,958,337
Warner Chilcott (US), LLC v. Zydus Pharms. (USA) Inc., 16-0323 (E.D. Tex.) Apr. 1, 2016 Hon. Rodney Gilstrap Delzicol® (mesalamine delayed-release capsules) 6,649,180
Lupin Ltd. v. Horizon Therapeutics, Inc., IPR2016-00829 (PTAB) Apr. 1, 2016 N/A Ravicti® (glycerol phenylbutyrate oral solution) 9.095.559
Millennium Pharms., Inc. v. Actavis LLC, 16-0223 (D. Del.) Apr. 4, 2016 Hon. Gregory M. Sleet Velcade® (bortezomib for injection) 6,713,446
Javelin Pharms., Inc. v. Mylan Labs. Ltd., 16-0224 (D. Del.) Apr. 4, 2016 Hon. Leonard P. Stark Dyloject® (diclofenac sodium for injection)
6,407,079
8,946,292
Abraxis Bioscience, LLC v. Actavis LLC, 16-1925 (D.N.J.) Apr. 6, 2016 Hon. John Michael Vazquez Abraxane® (albumin-bound paclitaxel for injection)
7,820,788
7,923,536
8,138,229
8,853,260
Javelin Pharms., Inc. v. Mylan Labs. Ltd., 16-0059 (N.D.W.V.) Apr. 6, 2016 Hon. Irene M. Keeley Dyloject® (diclofenac sodium for injection)
6,407,079
8,946,292
Acura Pharms., Inc. v. Purdue Pharma L.P., IPR2016-00849 (PTAB) Apr. 6, 2016 N/A OxyContin® (oxycodone tablets) 8,389,007
Fresenius Kabi USA, LLC v. Maia Pharms., Inc., 16-0237 (D. Del.) Apr. 7, 2016 Hon. Gregory M. Sleet Levothyroxine Sodium (levothyroxine sodium for injection)
9,006,289
9,168,238
9,168,239
Alcon Research, Ltd. v. Watson Labs., Inc., 16-0238 (D. Del.) Apr. 7, 2016 Hon. Richard G. Andrews Izba® (travoprost ophthalmic solution)
8,178,582
8,722,735
8,754,123
9,144,561
AstraZeneca Pharms. LP v. InnoPharma Licensing LLC, 16-1962 (D.N.J.) Apr. 7, 2016 Hon. Renee Marie Bumb Faslodex® (fulvestrant injection)
6,774,122
7,456,160
8,329,680
8,466,139
Bayer Intellectual Property GMBH v. Micro Labs Ltd., 16-0242 (D. Del.) Apr. 8, 2016 Hon. Sue L. Robinson Xarelto® (rivaroxaban tablets)
7,585,860
7,592,339
Takeda Pharm. Co. Ltd. v. Teva Pharms. USA, Inc., 16-0246 (D. Del.) Apr. 8, 2016 Hon. Leonard P. Stark Prevacid® SoluTab™ (lansoprazole delayed-release orally disintegrating tablets)
6,328,994
7,431,942
7,875,292
7,399,485
Upsher-Smith Labs., Inc. v. Zydus Pharms. (USA) Inc., 16-0248 (D. Del.) Apr. 8, 2016 Hon. Sue L. Robinson Qudexy® XR (topiramate extended-release capsules)
8,652,527
8,889,190
9,101,545
Fresenius Kabi USA, LLC v. B. Braun Medical Inc., 16-0250 (D. Del.) Apr. 11, 2016 Hon. Richard G. Andrews Diprivan® (propofol for injection) 8,476,010
Allergan, Inc. v. Famy Care Ltd., 16-0401 (E.D. Tex.) Apr. 12, 2016 Hon. Rodney Gilstrap Restasis® (cyclosporine ophthalmic emulsion)
8,629,111
8,633,162
8,642,556
8,648,048
8,685,930
9,248,191
Takeda GMBH v. Torrent Pharma Inc., 16-1280 (D.N.J.) Apr. 13, 2016 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets) 5,712,298
Galderma Labs., L.P. v. Akorn, Inc., 16-1012 (N.D. Tex.) Apr. 14, 2016 Hon. David C Godbey Clobex® (clobetasol propionate spray) 5,972,920
Forest Labs., LLC v. Apotex Corp., 16-0269 (D. Del.) Apr. 15, 2016 Hon. Gregory M. Sleet Teflaro® (ceftaroline fosamil injection) 6,417,175
Teva Pharms. USA, Inc. v. Biocon Ltd., 16-0278 (D. Del.) Apr. 19, 2016 Hon. Gregory M. Sleet Copaxone® (glatiramer acetate injection)
8,232,250
8,399,413
8,969,302
9,155,776
Sanofi-Aventis U.S. LLC v. Dr. Reddy's Labs., Inc., 16-2259 (D.N.J.) Apr. 21, 2016 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel solution for infusion) 5,847,170
Novartis AG v. Mylan Pharms. Inc., 16-0289 (D. Del.) Apr. 22, 2016 Hon. Leonard P. Stark Gilenya® (fingolimod capsules) 5,604,229
Senju Pharm. Co., Ltd. v. Hi-tech Pharmacal Co., Inc., 16-2270 (D.N.J.) Apr. 22, 2016 Hon. Jerome B. Simandle Prolensa® (bromfenac ophthalmic solution)
8,129,431
8,669,290
8,754,131
8,871,813
8,927,606
9,144,609
Par Pharm., Inc. v. Luitpold Pharms., Inc., 16-2290 (D.N.J.) Apr. 22, 2016 Hon. William H. Walls Adrenalin® (epinephrine injection)
9,119,876
9,295,657
Par Pharm., Inc. v. Luitpold Pharms., Inc., 16-1999 (E.D.N.Y.) Apr. 22, 2016 Hon. Ann M Donnelly Adrenalin® (epinephrine injection)
9,119,876
9,295,657
Galderma Labs., L.P. v. Tolmar Inc., 16-1099 (N.D. Tex.) Apr. 22, 2016 Hon. David C Godbey Epiduo® (adapalene and benzoyl peroxide gel)
8,071,644
8,080,537
8,129,362
8,445,543
8,809,305
Amneal Pharms. LLC v. GlaxoSmithKline LLC, 16-0300 (D. Del.) Apr. 25, 2016 Hon. Sue L. Robinson Lamictal XR® (lamotrigine extended-release tablets)
8,637,512
9,144,547
Boehringer Ingelheim Pharma GMBH & Co. KG v. Hetero USA, Inc., 16-2356 (D.N.J.) Apr. 26, 2016 Hon. Mary L. Cooper Pradaxa® (dabigatran etexilate mesylate capsules) 6,087,380
Boehringer Ingelheim Pharms. Inc. v. Dr. Reddy's Labs., Ltd., 16-2394 (D.N.J.) Apr. 28, 2016 Hon. Peter G. Sheridan
Tradjenta® (linagliptin tablets)

Jentadueto® (linagliptin / metformin hydrochloride tablets)
9,173,859
AstraZeneca AB v. Hetero USA Inc., 16-2442 (D.N.J.) Apr. 29, 2016 Hon. Mary L. Cooper Nexium® 24HR (esomeprazole magnesium delayed-release capsules)
6,369,085
7,411,070
Aurobindo Pharms. Ltd. v. Daiichi Sankyo, Inc., 16-4876 (N.D. Ill.) May 2, 2016 Hon. Rebecca R. Pallmeyer
Benicar® (olmesartan medoxomil tablets)

Benicar HZT® (olmesartan medoxomil / hydrochlorothiazide tablets)
6,878,703
BTG International Ltd. v. Amerigen Pharms., Inc., 16-2449 (D.N.J.) May 2, 2016 Hon. Kevin McNulty Zytiga® (abiraterone acetate tablets) 8,822,438
Otsuka Pharm. Co., Ltd. v. Zhejiang Huahai Pharm. Co., Ltd., 16-2475 (D.N.J.) May 2, 2016 Hon. Jerome B. Simandle, Abilify® (aripiprazole tablets) 8,759,350
Otsuka Pharm. Co., Ltd. v. Zhejiang Huahai Pharm. Co., Ltd., 16-2476 (D.N.J.) May 2, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,089,567
Endo Pharms. Inc. v. Impax Labs., Inc., 16-2526 (D.N.J.) May 4, 2016 Hon. Jose L. Linares Opana® ER (extended-release oxymorphone hydrochloride)
8,309,122
8,329,216
8,808,737
Leo Pharma A/S v. Actavis Labs. UT, Inc., 16-0333 (D. Del.) May 6, 2016 Hon. Sue L. Robinson Picato® (ingenol mebutate gel)
7,410,656
8,278,292
8,372,827
8,372,828
8,377,919
8,536,163
8,716,271
8,735,375
AstraZeneca LP v. Watson Labs., Inc., 16-0338 May 9, 2016 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,525,060
7,250,419
7,265,124
Breckenridge Pharm., Inc. v. Novartis AG, IPR2016-01023 (PTAB) May 10, 2016 N/A
Zortress® (everolimus tablets)

Afinitor® (everolimus tablets)

Afinitor® Disperz (everolimus oral suspension)
5,665,772
Rhodes Pharms. L.P. v. Actavis, Inc., 16-2667 (D.N.J.) May 11, 2016 Hon. William H. Walls Aptensio XR® (methylphenidate hydrochloride extended-release capsules)
6,419,960
7,083,808
7,247,318
7,438,930
8,580,310
9,066,869
Mylan Institutional LLC v. Aurobindo Pharma Ltd., 16-0491 (E.D. Tex.) May 11, 2016 Hon. Robert W. Schroeder, III Isosulfan blue (isosulfan blue)
7,662,992
8,969,616
Amneal Pharma. LLC v. Purdue Pharma L.P., IPR2016-01027 (PTAB) May 11, 2016 N/A OxyContin® (oxycodone hydrochloride extended-release tablets) 9,060,976
Amneal Pharma. LLC v. Purdue Pharma L.P., IPR2016-01028 (PTAB) May 11, 2016 N/A OxyContin® (oxycodone hydrochloride extended-release tablets) 9,060,976
Wockhardt Bio AG v. AstraZeneca AB, IPR2016-01029 (PTAB) May 11, 2016 N/A
Kombiglyze® XR (metformin hydrochloride / saxagliptin hydrochloride extended-release tablets)

Onglyza® (saxagliptin hydrochloride tablets)
RE44,186
Mylan Pharms Inc. v. Shire Labs., Inc., IPR2016-01033 (PTAB) May 12, 2016 N/A Adderall® XR (amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate extended-release capsules) RE42,096
Santen Pharm. Co., Ltd. v. Micro Labs Ltd., 16-0353 (D. Del.) May 13, 2016 Hon. Gregory M. Sleet Zioptan® (tafluprost ophthalmic solution) 5,886,035
Santen Pharm. Co., Ltd. v. Sandoz Inc., 16-0354 (D. Del.) May 13, 2016 Hon. Gregory M. Sleet Zioptan® (tafluprost ophthalmic solution) 5,886,035
Par Pharm., Inc. v. Novartis AG, IPR2016-01059 (PTAB) May 17, 2016 N/A
Zortress® (everolimus tablets)

Afinitor® (everolimus tablets)

Afinitor® Disperz (everolimus oral suspension)
5,665,772
ApoPharma Inc. v. Taro Pharm. Indus., Ltd., 16-0528 (E.D. Tex.) May 18, 2016 Hon. Robert W. Schroeder, III Ferriprox® (deferiprone tablets) 7,049,328
Novartis AG v. Mylan Pharms. Inc., 16-0093 (N.D.W.V.) May 18, 2016 Hon. Irene M. Keeley Gilenya® (fingolimod capsules) 5,604,229
Forest Labs., LLC v. Accord Healthcare, Inc., 16-0375 (D. Del.) May 20, 2016 Hon. Leonard P. Stark Namzaric® (memantine hydrochloride / donepezil hydrochloride extended-release capsules)
8,039,009
8,058,291
8,168,209
8,173,708
8,283,379
8,293,794
8,329,752
8,338,485
8,338,486
8,362,085
8,580,858
8,598,233
Lotus Pharm. Co., Ltd. v. GlaxoSmithKline LLC, 16-0377 (D. Del.) May 20, 2016 Hon. Gregory M. Sleet Lamictal XR® (lamotrigine extended-release tablets)
8,637,512
9,144,547
Mylan Pharms., Inc. v. Research Corp. Technologies, Inc., IPR2016-01101 (PTAB) May 25, 2016 N/A Vimpat® (lacosamide) RE38,551
Allergan, Inc. v. Somerset Therapeutics, LLC, 16-0392 (D. Del.) May 26, 2016 Hon. Gregory M. Sleet Lastacaft® (alcaftadine ophthalmic solution) 8,664,215
Roxane Labs., Inc. v. Novartis AG, IPR2016-01102 (PTAB) May 26, 2016 N/A
Zortress® (everolimus tablets)

Afinitor® (everolimus tablets)

Afinitor® Disperz (everolimus oral suspension)
5,665,772
Breckenridge Pharm., Inc. v. Novartis AG, IPR2016-01103 (PTAB) May 26, 2016 N/A
Zortress® (everolimus tablets)

Afinitor® (everolimus tablets)

Afinitor® Disperz (everolimus oral suspension)
5,665,772
Alvogen Pine Brook LLC v. Noven Pharms., Inc., 16-0395 May 27, 2016 Hon. Leonard P. Stark Minivelle® (estradiol extended-release film)
6,841,716
8,231,906
Orexo AB v. Actavis Elizabeth LLC, 16-0397 (D. Del.) May 27, 2016 Hon. Sue L. Robinson Zubsolv® (buprenorphine hydrochloride / naloxone hydrochloride sublingual tablets) 9,259,421
AbbVie Inc. v. Amneal Pharms., LLC, 16-0398 (D. Del.) May 27, 2016 Hon. Richard G. Andrews Norvir® (ritonavir tablets)
7,148,359
7,364,752
Luye Pharma Group Ltd. v. Alkermes Pharma Ireland Ltd, IPR2016-01095 (PTAB) May 31, 2016 N/A
Bydureon® (exenatide synthetic extended-release suspension)

Vivitrol® (naltrexone extended-release suspension)

Risperdal® (risperidone for injection)
6,667,061
Luye Pharma Group Ltd. v. Alkermes Pharma Ireland Ltd, IPR2016-01096 (PTAB) May 31, 2016 N/A
Bydureon® (exenatide synthetic extended-release suspension)

Vivitrol® (naltrexone extended-release suspension)

Risperdal® (risperidone for injection)
6,667,061
Dr. Reddyy's Labs., Ltd v. MonoSol RX, LLC, IPR2016-01111 (PTAB) May 31, 2016 N/A Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride film) 8,603,514
Dr. Reddyy's Labs., Ltd v. MonoSol RX, LLC, IPR2016-01112 (PTAB) May 31, 2016 N/A Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride film) 8,017,150
Dr. Reddyy's Labs., Ltd v. Indivior UK Limited f/k/a RB Pharms. Ltd., IPR2016-01113 (PTAB) May 31, 2016 N/A Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride film) 8,475,832
Sun Pharm. Indus., Ltd. v. AstraZeneca AB, IPR2016-01104 (PTAB) June 1, 2016 N/A
Kombiglyze® XR (metformin hydrochloride / saxagliptin hydrochloride extended-release tablets)

Onglyza® (saxagliptin hydrochloride tablets)
RE44,186
Teva Pharms. USA, Inc. v. AstraZeneca AB, IPR2016-01122 (PTAB) June 1, 2016 N/A
Kombiglyze® XR (metformin hydrochloride / saxagliptin hydrochloride extended-release tablets)

Onglyza® (saxagliptin hydrochloride tablets)
RE44,186
Aurobindo Pharma U.S.A., Inc. v. AstraZeneca AB, IPR2016-01117 (PTAB) June 2, 2016 N/A
Kombiglyze® XR (metformin hydrochloride / saxagliptin hydrochloride extended-release tablets)

Onglyza® (saxagliptin hydrochloride tablets)
RE44,186
Mylan Pharms. Inc. v. Allergan, Inc., IPR2016-01127 (PTAB) June 3, 2016 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,685,930
Mylan Pharms. Inc. v. Allergan, Inc., IPR2016-01128 (PTAB) June 3, 2016 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,629,111
Mylan Pharms. Inc. v. Allergan, Inc., IPR2016-01129 (PTAB) June 3, 2016 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,642,556
Mylan Pharms. Inc. v. Allergan, Inc., IR2016-01130 (PTAB) June 3, 2016 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,633,162
Mylan Pharms. Inc. v. Allergan, Inc., IPR2016-01131 (PTAB) June 3, 2016 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,648,048
Mylan Pharms. Inc. v. Allergan, Inc., IPR2016-01132 (PTAB) June 3, 2016 N/A Restasis® (cyclosporine ophthalmic emulsion) 9,248,191
Mylan Pharms., Inc. v. Senju Pharm. Co., Ltd., IPR2016-01163 (PTAB) June 8, 2016 N/A Bepreve® (bepotastine besilate ophthalmic solution) 8,877,168
Aurobindo Pharma USA Inc. v. Apicore US LLC, 16-3358 (D.N.J.) June 9, 2016 Hon. Renee Marie Bumb Isosulfan blue (isosulfan blue)
7,662,992
8,969,616
9,353,050
Leo Pharma A/S v. Perrigo UK Finco Ltd. Partnership, 16-0430 (D. Del.) June 10, 2016 Hon. Sue L. Robinson Picato® (ingenol mebutate gel)
6,432,452
6,787,161
6,844,013
7,410,656
8,278,292
8,372,827
8,372,828
8,377,919
8,536,163
8,716,271
8,735,375
Novartis Pharms. Corp. v. Breckenridge Pharm., Inc., 16-0431 (D. Del.) June 10, 2016 Hon. Richard G. Andrews Afinitor® (everolimus tablets)
5,665,772
8,410,131
8,778,962
Purdue Pharma L. P. v. Collegium Pharm., Inc., 16-11091 (D. Mass.) June 10, 2016 Hon. F. Dennis Saylor, IV
OxyContin® (oxycodone)

Xtampza ER™ (oxycodone)
9,155,717
UCB, Inc. v. Aurobindo Pharma Ltd., 16-0451 (D. Del.) June 17, 2016 Hon. Leonard P. Stark Vimpat® (lacosamide) RE38,551
UCB, Inc. v. Hetero USA Inc., 16-0452 (D. Del.) June 17, 2016 Hon. Leonard P. Stark Vimpat® (lacosamide) RE38,551
Shire Orphan Therapies LLC v. InnoPharma, Inc., 16-0456 (D. Del.) June 17, 2016 Hon. Gregory M. Sleet Firazyr® (icatibant for injection) 5,648,333
United Therapeutics Corp. v. Actavis Labs. FL, Inc., 16-3642 (D.N.J.) June 17, 2016 Hon. Peter G. Sheridan Orenitram® (treprostinil extended-release tablets)
7,417,070
7,544,713
8,252,839
8,349,892
8,410,169
8,497,393
9,050,311
8,747,897
9,278,901
Noven Pharms., Inc. v. Actavis Labs. UT, Inc., 16-0465 (D. Del.) June 20, 2016 Hon. Leonard P. Stark Minivelle® (estradiol transdermal system) 8,231,906
Eli Lilly and Co. v. Apotex Inc., 16-1512 (S.D. Ind.) June 20, 2016 Hon. William T. Lawrence Axiron® (testosterone metered transdermal solution)
8,419,307
8,177,449
8,435,944
8,807,861
8,993,520
9,180,194
9,289,586
Breckenridge Pharm., Inc. v. Research Corp. Technologies, Inc., IPR2016-01242 (PTAB) June 21, 2016 N/A Vimpat® (lacosamide) RE38,551
Eli Lilly and Co. v. Apotex Inc., 16-0475 (D. Del.) June 22, 2016 Hon. Leonard P. Stark Axiron® (testosterone metered transdermal solution)
8,419,307
8,177,449
8,435,944
8,807,861
8,993,520
9,180,194
9,289,586
Argentum Pharms. LLC v. Allergan, Inc., IPR2016-01232 (PTAB) June 22, 2016 N/A Restasis® (cyclosporine ophthalmic emulsion) 8,629,111
Alembic Pharms., Ltd.v. Research Corp. Technologies, Inc., IPR2016-01245 (PTAB) June 22, 2016 N/A Vimpat® (lacosamide) RE38,551
Gilead Sciences, Inc. v. Aurobindo Pharma Ltd., 16-3722 (D.N.J.) June 23, 2016 Hon. Renee Marie Bumb Emtriva® (emtricitabine capsules)
6,642,245
6,703,396
Mylan Pharms., Inc. v. Research Corp. Technologies, Inc., IPR2016-01248 (PTAB) June 23, 2016 N/A Vimpat® (lacosamide) RE38,551
BTG Int'l Ltd. v. Glenmark Pharms. Inc., USA, 16-3743 (D.N.J.) June 24, 2016 Hon. Kevin McNulty Zytiga® (abiraterone acetate tablets) 8,822,438
Apotex Inc. v. Osi Pharms., Inc., IPR2016-01284 (PTAB) June 28, 2016 N/A Tarceva® (erlotinib hydrochloride tablets) 6,900,221
Genzyme Corp. v. Zydus Pharms. (USA) Inc., 16-0540 (D. Del.) June 29, 2016 Hon. Gregory M. Sleet Mozobil® (plerixafor for injection)
7,897,590
6,987,102
Janssen Pharmaceutica N.V. v. Xellia Pharms ApS, 16-0554 (D. Del.) June 29, 2016 Hon. Leonard P. Stark Sporanox® (voriconazole for injection) 6,407,079
Genzyme Corp. v. Amneal Pharms. LLC, 16-3892 (D.N.J.) June 29, 2016 Hon. Stanley R. Chesler Clolar® (clofarabine for injection) 5,661,136
Mylan Pharms., Inc. v. AstraZeneca AB, IPR2016-01316 (PTAB) June 29, 2016 N/A Faslodex® (fulvestrant injection) 6,774,122
Argentum Pharms. LLC v. Janssen Oncology, Inc., IPR2016-01317 (PTAB) June 29, 2016 N/A Zytiga® (abiraterone acetate tablets) 8,822,438
Mylan Pharms., Inc. v. AstraZeneca AB, IPR2016-01324 (PTAB) June 29, 2016 N/A Faslodex® (fulvestrant injection) 7,456,160
Mylan Pharms., Inc. v. AstraZeneca AB, IPR2016-01325 (PTAB) June 29, 2016 N/A Faslodex® (fulvestrant injection) 8,329,680
Mylan Pharms., Inc. v. AstraZeneca AB, IPR2016-01326 (PTAB) June 29, 2016 N/A Faslodex® (fulvestrant injection) 8,466,139
Alcon Pharms. Ltd. v. Imprimis Pharms., Inc., 16-0563 (D. Del.) June 30, 2016 Hon. Sue L. Robinson Vigamox® (moxifloxacin hydrochloride ophthalmic solution)
6,716,830
7,671,070
Genzyme Corp. v. Zydus Pharms. (USA) Inc., 16-3905 (D.N.J.) June 30, 2016 Hon. Renee Marie Bumb Mozobil® (plerixafor for injection)
7,897,590
6,987,102
Horizon Therapeutics, Inc. v. Par Pharm., Inc., 16-3910 (D.N.J.) June 30, 2016 Hon. Robert B. Kugler Ravicti® (glycerol phenylbutyrate oral solution)
9,095,559
9,254,278
9,326,966
Mylan Pharms., Inc. v. Janssen Oncology, Inc., IPR2016-01332 (PTAB) June 30, 2016 N/A Zytiga® (abiraterone acetate tablets) 8,822,438
Wockhardt Bio AG v. Eli Lilly and Co., IPR2016-01335 (PTAB) June 30, 2016 N/A Alimta® (pemetrexed disodium for injection) 7,772,209
Wockhardt Bio AG v. Eli Lilly and Co., IPR2016-01337 (PTAB) June 30, 2016 N/A Alimta® (pemetrexed disodium for injection) 7,772,209

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.